Cellectis (CLLS) FCF Margin: 2015-2023
Historic FCF Margin for Cellectis (CLLS) over the last 9 years, with Sep 2023 value amounting to -9,233.55%.
- Cellectis' FCF Margin rose 413102.00% to -9,233.55% in Q3 2023 from the same period last year, while for Sep 2023 it was -413.01%, marking a year-over-year increase of 53371.00%. This contributed to the annual value of -349.37% for FY2022, which is 3042.00% down from last year.
- Latest data reveals that Cellectis reported FCF Margin of -9,233.55% as of Q3 2023, which was down 1.07% from -9,135.39% recorded in Q2 2023.
- Cellectis' FCF Margin's 5-year high stood at 6.70% during Q1 2020, with a 5-year trough of -18,387.05% in Q1 2023.
- In the last 3 years, Cellectis' FCF Margin had a median value of -1,582.79% in 2022 and averaged -4,985.28%.
- Examining YoY changes over the last 5 years, Cellectis' FCF Margin showed a top increase of 413,102bps in 2023 and a maximum decrease of 1,635,696bps in 2023.
- Cellectis' FCF Margin (Quarterly) stood at -413.75% in 2019, then plummeted by 22,777bps to -641.52% in 2020, then skyrocketed by 16,335bps to -478.17% in 2021, then skyrocketed by 40,329bps to -74.88% in 2022, then spiked by 413,102bps to -9,233.55% in 2023.
- Its FCF Margin was -9,233.55% in Q3 2023, compared to -9,135.39% in Q2 2023 and -18,387.05% in Q1 2023.